Tower Research Capital (TRC)’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2K | Buy |
5,587
+1,053
| +23% | +$3.61K | ﹤0.01% | 3706 |
|
|
2025
Q1 | $10.1K | Sell |
4,534
-7,676
| -63% | -$17.1K | ﹤0.01% | 3677 |
|
|
2024
Q4 | $35.8K | Sell |
12,210
-3,773
| -24% | -$11.1K | ﹤0.01% | 2780 |
|
|
2024
Q3 | $41.6K | Buy |
15,983
+5,203
| +48% | +$13.5K | ﹤0.01% | 2824 |
|
|
2024
Q2 | $31.9K | Buy |
10,780
+6,406
| +146% | +$19K | ﹤0.01% | 3436 |
|
|
2024
Q1 | $19.8K | Sell |
4,374
-1,911
| -30% | -$8.66K | ﹤0.01% | 3008 |
|
|
2023
Q4 | $35.9K | Sell |
6,285
-2,186
| -26% | -$12.5K | ﹤0.01% | 3329 |
|
|
2023
Q3 | $39K | Sell |
8,471
-40,076
| -83% | -$184K | ﹤0.01% | 2771 |
|
|
2023
Q2 | $314K | Buy |
48,547
+43,160
| +801% | +$279K | 0.01% | 1258 |
|
|
2023
Q1 | $41K | Sell |
5,387
-8,752
| -62% | -$66.6K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $143K | Sell |
14,139
-1,551
| -10% | -$15.7K | 0.01% | 1552 |
|
|
2022
Q3 | $155K | Buy |
15,690
+10
| +0.1% | +$99 | ﹤0.01% | 2164 |
|
|
2022
Q2 | $167K | Buy |
15,680
+14,123
| +907% | +$150K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $15K | Buy |
1,557
+755
| +94% | +$7.27K | ﹤0.01% | 3788 |
|
|
2021
Q4 | $12K | Sell |
802
-682
| -46% | -$10.2K | ﹤0.01% | 4251 |
|
|
2021
Q3 | $30K | Buy |
1,484
+1,416
| +2,082% | +$28.6K | ﹤0.01% | 3369 |
|
|
2021
Q2 | $1K | Sell |
68
-3,396
| -98% | -$49.9K | ﹤0.01% | 5161 |
|
|
2021
Q1 | $118K | Buy |
3,464
+3,110
| +879% | +$106K | ﹤0.01% | 2461 |
|
|
2020
Q4 | $14K | Buy |
+354
| New | +$14K | ﹤0.01% | 4079 |
|